title: Medical Comorbidity and Complications.
abstract: Like their peers in the general youth population, youth with chronic medical conditions (YCMC) are at risk for substance use, including nonmedical use of prescription medications. However, given dangerous disease-substance interactions, the stakes for detecting and intervening on substance use are perhaps even higher for YCMC. Given the risk for nonadherence with chronic disease management, it is incumbent on primary care providers, specialty providers, and behavioral health specialists to be vigilant in asking about substance use and providing brief counseling and referral to substance use treatment when appropriate.
authors.affiliation: Division of Adolescent/Young Adult Medicine, Department of Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Kresge Building, 677 Huntington Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: scott.hadland@childrens.harvard.edu.
authors.forename: Scott E
authors.initials: SE
authors.lastname: Hadland
authors.affiliation: Division of Adolescent Medicine, Seattle Children's Hospital, 4800 Sand Point Way Northeast, Seattle, WA 98105, USA; Department of Pediatrics, University of Washington, 1959 Northeast Pacific Street, Box 356320, Seattle, WA 98195, USA.
authors.forename: Leslie Renee
authors.initials: LR
authors.lastname: Walker
mesh_terms: D002908:Chronic Disease; D015897:Comorbidity; D003376:Counseling / Q000379:methods*; D006801:Humans; D055553:Prescription Drugs / Q000009:adverse effects*; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000209:etiology / Q000628:therapy*
chemical_list: D055553:Prescription Drugs
keywords: Adolescents; Chronic disease; Electronic cigarettes; Ethanol; Street drugs; Substance-related disorders; Tobacco products